Literature DB >> 7869964

Detection of west Nile and Japanese encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan.

A Igarashi1, M Tanaka, K Morita, T Takasu, A Ahmed, A Ahmed, D S Akram, M A Waqar.   

Abstract

Reverse transcriptase-polymerase chain reaction (RT-PCR) on 24 cerebrospinal fluid (CSF) specimens collected between February and August 1992 detected genome sequence of West Nile (WN) virus in 8 specimens and Japanese encephalitis (JE) virus in a single specimen. The results, combined with the data by IgM-ELISA on CSF indicated that a significant proportion of acute encephalitis cases in Karachi, Pakistan, were caused by WN virus infection, while JE virus caused a small fraction.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7869964     DOI： 10.1111/j.1348-0421.1994.tb01866.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN： 0385-5600            Impact factor:   1.955


  37 in total

1.  Japanese encephalitis.

Authors:  T Solomon; N M Dung; R Kneen; M Gainsborough; D W Vaughn; V T Khanh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

2.  A DNA prime, orally delivered protein boost vaccination strategy against viral encephalitis.

Authors:  Mark P Zanin; Diane E Webster; Steven L Wesselingh
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

3.  Persistent West Nile virus transmission and the apparent displacement St. Louis encephalitis virus in southeastern California, 2003-2006.

Authors:  William K Reisen; Hugh D Lothrop; Sarah S Wheeler; Marc Kennsington; Arturo Gutierrez; Ying Fang; Sandra Garcia; Branka Lothrop
Journal:  J Med Entomol       Date:  2008-05       Impact factor: 2.278

4.  Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia.

Authors:  Amy J Schuh; Melissa J Ward; Andrew J Leigh Brown; Alan D T Barrett
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

5.  Genetic characterization of Japanese encephalitis virus genotype II strains isolated from 1951 to 1978.

Authors:  Amy J Schuh; Robert B Tesh; Alan D T Barrett
Journal:  J Gen Virol       Date:  2010-12-01       Impact factor: 3.891

6.  Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo.

Authors:  Ana P Goncalvez; Cheng-Hsin Chien; Kamolchanok Tubthong; Inna Gorshkova; Carrie Roll; Olivia Donau; Peter Schuck; Sutee Yoksan; Sy-Dar Wang; Robert H Purcell; Ching-Juh Lai
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

Review 7.  Present and future arboviral threats.

Authors:  Scott C Weaver; William K Reisen
Journal:  Antiviral Res       Date:  2009-10-24       Impact factor: 5.970

8.  Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans.

Authors:  Byung-Hak Song; Gil-Nam Yun; Jin-Kyoung Kim; Sang-Im Yun; Young-Min Lee
Journal:  J Microbiol       Date:  2012-08-25       Impact factor: 3.422

Review 9.  Preventive strategies for frequent outbreaks of Japanese encephalitis in Northern India.

Authors:  Vandana Saxena; Tapan N Dhole
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

10.  Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance.

Authors:  Susan Hills; Alya Dabbagh; Julie Jacobson; Anthony Marfin; David Featherstone; Joachim Hombach; Pem Namgyal; Manju Rani; Tom Solomon
Journal:  BMC Infect Dis       Date:  2009-12-29       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.